4//SEC Filing
MCCLUNG BARBARA G 4
Accession 0001209191-21-061294
CIK 0001619856other
Filed
Oct 20, 8:00 PM ET
Accepted
Oct 21, 6:12 PM ET
Size
11.8 KB
Accession
0001209191-21-061294
Insider Transaction Report
Form 4
MCCLUNG BARBARA G
Chief Legal Officer
Transactions
- Purchase
Common Stock
2021-10-20$2.69/sh+9,176$24,683→ 342,801 total - Purchase
Common Stock
2021-10-20$2.69/sh+43$116→ 342,844 total - Exercise of In-Money
Option to purchase Common Stock
2021-10-20−9,176→ 80,951 totalExercise: $2.69Exp: 2029-09-30→ Common Stock (9,176 underlying) - Exercise of In-Money
Option to purchase Common Stock
2021-10-20−43→ 89 totalExercise: $2.69Exp: 2028-06-11→ Common Stock (43 underlying)
Footnotes (5)
- [F1]These shares were acquired pursuant to the exercise of a stock option, as reported in Table II below.
- [F2]The exercise price for this stock option was incorrectly reported as $2.68 per share on the reporting person's Form 3 filed on July 22, 2021.
- [F3]The amount of securities beneficially owned was incorrectly reported as 333,626 shares on the reporting person's Form 3 filed on July 22, 2021. The correct number is 333,625.
- [F4]The shares subject to this option have vested or will vest in equal monthly installments until the option is fully vested on October 1, 2023, subject to the reporting person's continued service to the Issuer through the applicable vesting dates.
- [F5]The shares subject to this option have vested or will vest in equal monthly installments until the option is fully vested on June 12, 2022, subject to the reporting person's continued service to the Issuer through the applicable vesting dates.
Documents
Issuer
Caribou Biosciences, Inc.
CIK 0001619856
Entity typeother
Related Parties
1- filerCIK 0001231321
Filing Metadata
- Form type
- 4
- Filed
- Oct 20, 8:00 PM ET
- Accepted
- Oct 21, 6:12 PM ET
- Size
- 11.8 KB